January 2023
Industry veteran Gloria Vanderham will lead as Chief Executive Officer to help clients across the health continuum disrupt the healthcare ecosystem and remove barriers to optimal care with an unrelenting focus on the whole person and their health journey.
Vanderham is an industry recognized and values driven leader who has more than two decades of global, regional and local country experience in communications, digital and social media marketing. She understands the challenges and opportunities from the agency and in-house perspectives and brings invaluable patient insights to drive business impact for our clients and strong leadership for our teams.
Most recently, Gloria Vanderham lived in Basel, Switzerland where she was Region Europe Head of Communications at Novartis AG. Previous roles include leadership positions at Novartis Pharmaceuticals, Johnson & Johnson and Fleishman-Hillard. Gloria is a Rutgers University alumna, member of the Healthcare Businesswomen’s Association and current Vice Chair of the Executive Committee of the Rutgers University Alumni Association Board of Directors.
“It is an honor to lead Bliss Bio Health. I am energized by the teams’ exemplary talent, passion, agility, entrepreneurial spirit and alignment with our purpose to make a measurable difference for people living with a disease.” Gloria Vanderham said. “We have a responsibility to do better and offer unique approaches that promote clarity, collaboration and collective healthcare ecosystem progress. We will attract team members, partners and clients who want to be a part of the solution.”
Michael Roth, Founder and Managing Partner at The Bliss Group, who created and shaped its healthcare vertical, will take on the role of Chair of Bliss Bio Health.
“The presence of healthcare marketing and communications teams who truly understand the science, patient experience and the business of health—equally—is paramount to the evolution of the industry,” Michael Roth said. “Over the years, we learned that the integration of these three disciplines leads to a real white space in healthcare. From powering clinical trials through our CTRx Pathways program and creating compelling integrated campaigns to advocating for equity in healthcare access and driving healthcare policy communications, we’re enabling better outcomes in care.”
Bliss Bio Health will focus on early-stage science, R&D, pre-launch through post-launch strategies, commercialization, health programs, and patient engagement. The company will unite strategies for clients, spot trends in the industry, enable collaboration with new partners and facilitate fully integrated innovative advertising, marketing, public affairs and communications programs.
Gloria Vanderham will begin as Chief Executive Officer effective February 1.